China Universal Asset Management Company’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61.9K | Buy |
17,188
+246
| +1% | +$886 | 0.01% | 406 |
|
|
2025
Q1 | $50.7K | Sell |
16,942
-967
| -5% | -$2.89K | ﹤0.01% | 420 |
|
|
2024
Q4 | $60K | Buy |
17,909
+1,672
| +10% | +$5.6K | 0.01% | 440 |
|
|
2024
Q3 | $54.4K | Buy |
16,237
+6,343
| +64% | +$21.2K | 0.01% | 382 |
|
|
2024
Q2 | $32.7K | Sell |
9,894
-6,285
| -39% | -$20.8K | ﹤0.01% | 378 |
|
|
2024
Q1 | $65.4K | Buy |
16,179
+6,526
| +68% | +$26.4K | 0.01% | 398 |
|
|
2023
Q4 | $29.4K | Buy |
9,653
+7,514
| +351% | +$22.9K | 0.01% | 402 |
|
|
2023
Q3 | $6.42K | Buy |
2,139
+1,046
| +96% | +$3.14K | ﹤0.01% | 374 |
|
|
2023
Q2 | $4.09K | Sell |
1,093
-36
| -3% | -$135 | ﹤0.01% | 386 |
|
|
2023
Q1 | $3.78K | Buy |
1,129
+283
| +33% | +$948 | ﹤0.01% | 393 |
|
|
2022
Q4 | $4.07K | Buy |
846
+66
| +8% | +$317 | ﹤0.01% | 318 |
|
|
2022
Q3 | $4K | Buy |
+780
| New | +$4K | ﹤0.01% | 289 |
|